This company listing is no longer active
Singapore Medical Group Crecimiento futuro
Future controles de criterios 2/6
Información clave
7.7%
Tasa de crecimiento de los beneficios
7.8%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Healthcare | 17.8% |
Tasa de crecimiento de los ingresos | 5.3% |
Rentabilidad financiera futura | 8.9% |
Cobertura de analistas | Low |
Última actualización | n/a |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2024 | 121 | 18 | N/A | 23 | 1 |
12/31/2023 | 116 | 17 | N/A | 22 | 1 |
12/31/2022 | 111 | 15 | N/A | 21 | 1 |
6/30/2022 | 105 | 15 | 23 | 25 | N/A |
3/31/2022 | 103 | 15 | 22 | 25 | N/A |
12/31/2021 | 101 | 16 | 20 | 24 | N/A |
9/30/2021 | 99 | 14 | 19 | 23 | N/A |
6/30/2021 | 98 | 12 | 17 | 21 | N/A |
3/31/2021 | 93 | 11 | 18 | 21 | N/A |
12/31/2020 | 87 | 9 | 19 | 21 | N/A |
9/30/2020 | 89 | 10 | 22 | 24 | N/A |
6/30/2020 | 89 | 10 | 23 | 24 | N/A |
3/31/2020 | 93 | 12 | 25 | 26 | N/A |
12/31/2019 | 95 | 14 | 24 | 26 | N/A |
9/30/2019 | 91 | 13 | 22 | 24 | N/A |
6/30/2019 | 89 | 13 | 19 | 21 | N/A |
3/31/2019 | 87 | 13 | 15 | 19 | N/A |
12/31/2018 | 85 | 13 | 14 | 17 | N/A |
9/30/2018 | 82 | 12 | 10 | 16 | N/A |
6/30/2018 | 78 | 11 | 9 | 16 | N/A |
3/31/2018 | 73 | 10 | 8 | 14 | N/A |
12/31/2017 | 68 | 8 | 8 | 13 | N/A |
9/30/2017 | 60 | 7 | 6 | 9 | N/A |
6/30/2017 | 53 | 6 | 5 | 6 | N/A |
3/31/2017 | 46 | 4 | 5 | 6 | N/A |
12/31/2016 | 42 | 2 | 3 | 5 | N/A |
9/30/2016 | 39 | 2 | 3 | 4 | N/A |
6/30/2016 | 36 | 1 | 2 | 3 | N/A |
3/31/2016 | 33 | 0 | N/A | 2 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: 5OT's forecast earnings growth (7.7% per year) is above the savings rate (1.9%).
Beneficios vs. Mercado: 5OT's earnings (7.7% per year) are forecast to grow faster than the SG market (5.2% per year).
Beneficios de alto crecimiento: 5OT's earnings are forecast to grow, but not significantly.
Ingresos vs. Mercado: 5OT's revenue (5.3% per year) is forecast to grow slower than the SG market (6% per year).
Ingresos de alto crecimiento: 5OT's revenue (5.3% per year) is forecast to grow slower than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: 5OT's Return on Equity is forecast to be low in 3 years time (8.9%).